Lv4
500 积分 2022-06-23 加入
Trastuzumab deruxtecan (DS-8201a) in patients with advanced HER2-positive breast cancer previously treated with trastuzumab emtansine: a dose-expansion, phase 1 study
1个月前
已完结
Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice
1个月前
已完结
On translation of antibody drug conjugates efficacy from mouse experimental tumors to the clinic: a PK/PD approach
1个月前
已完结
Results of a phase I clinical trial of cetuximab biosimilar (RPH-002)
1个月前
已关闭
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
1个月前
已完结
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab
3个月前
已完结
皖公网安备34019202002308
